4.7 Article

Multiple Human Papillomavirus Infections and Type Competition in Men

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 205, Issue 1, Pages 72-81

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jir709

Keywords

-

Funding

  1. National Cancer Institute, National Institutes of Health (NIH) [R01 CA114773-04]
  2. Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH [AI50440]
  3. Canadian Institutes of Health Research (CIHR) [HCT 44180]
  4. NIH [T32 AI070114]
  5. UNC-GSK Center of Excellence in Pharmacoepidemiology
  6. GlaxoSmithKline
  7. Merck Corporation

Ask authors/readers for more resources

Background. There is little information on multiple human papillomavirus (HPV) infections and the potential for type competition in men, yet competition may impact the type-specific efficacy of HPV vaccination. Methods. Among 2702 uncircumcised men in Kisumu, Kenya, who were seronegative for human immunodeficiency virus, the observed numbers of HPV types detected were compared with the expected number, which was simulated under the assumption of independent infections. To assess the potential for HPV type competition, adjusted odds ratios for pairwise combinations of prevalent HPV type infections were estimated using semi-Bayesian methods. Results. Half of all men were HPV positive, of whom 57% had multiple HPV types. We observed men without HPV infection and with >= 4 HPV types more often than expected if infections were independent. No negative associations between individual HPV types were observed. HPV types 31, 39, 56, 58, and 59 were positively associated with both carcinogenic vaccine types HPV-16 and HPV-18 (2-sided P value,. 05). Conclusions. Men who were HPV infected were likely to test positive for >1 HPV type. Cross-sectional associations between individual HPV types were positive and did not appear to be type-specific. Thus, we did not identify HPV types that are candidates for potential HPV type competition in men.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available